IGF-Child-Turcotte-Pugh score as a predictor of treatment outcome in Child-Pugh A, advanced hepatocellular carcinoma patients undergoing sorafenib therapy.

Mohamed, YI; Qayyum, A; Hassan, M; Xiao, LC; Duda, DG; Hatia, R; Lee, SS; Wolff, RA; Morris, J; Altameemi, L; Yao, JC; Amin, HM; Kaseb, AO; Kaseb's

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (15):